The Supreme Court ruled unanimously on Monday against the NCAA and limits on academic-related benefits for student athletes. This ruling was narrow in that it has nothing to do with college athletes making money off of their image, name, and likeness or payments for on-field achievements. With this ruling, colleges may offer greater benefits such as graduate student scholarships, internships, computer equipment and more. Ben Strauss, sports and media reporter at the Washington Post, joins just for what this means for the movement to increase compensation for student athletes.

Next, more companies are pushing for employees to prove they are vaccinated for Covid-19. Most employers have not mandated that workers get vaccinated, but are implementing policies for those who choose not to get the shots like continued mask wearing. Employers are bolstered by new guidance that says they can require all workers entering a workplace to be vaccinated. Orla McCaffrey, consumer finance reporter at the WSJ, joins us for what to know.

Finally, the first new Alzheimer’s drug approved in almost 20 years is providing a lot of hope for those afflicted with the disease, but it is causing headaches for lawmakers in Washington. The high cost of the treatment, if approved by Medicare, could cost the government almost $57 billion a year. Benjy Sarlin, policy editor at NBC News, joins us for how taxpayers and patients could be squeezed by a costly drug whose benefits are questionable.

Learn more about your ad-choices at https://www.iheartpodcastnetwork.com

See omnystudio.com/listener for privacy information.